MUC5B levels in submandibular gland saliva of patients treated with radiotherapy for head-and-neck cancer: a pilot study.

Radiat Oncol · 2012 · PMC3434044 · PMID 22704532

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

borderline significantp = 0.055so close (0.05 < p ≤ 0.1)

Repeating the analyses without these two extremes showed a borderline significant higher MUC5B level in the patients with no or mild xerostomia (median 0.14 vs 0.00 U, p = 0.055) at 12 months.

also in 11,409 other papers

showed a trendno p-value reported

This pilot study showed a trend towards lower MUC5B levels in the SMG saliva of patients with severe xerostomia 12 months after RT for HNC.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.